Show metadata Hide metadata

(19)

(11)

2 453 328

(13)

(51)

IPC

A61K38/08(2006-01-01)

A61K38/12(2006-01-01)

A61K38/33(2006-01-01)

A61P5/50(2006-01-01)

(21) (22)

Application

2010122897/15, 2008-11-05

(24)

Start date

2008-11-05

(22)

Actual filing date

2008-11-05

(45)

Published

2012-06-20

(72)

Inventor

Khejlem Khehzer A.Kaller Majkl DevittBatler Ehndrju A.

(73)

Holder

Ipsen Farma S.A.S.Bord Of S'Jupervajzorz Of Luiziana Stehjt Juniversiti Ehnd Ehgrikalcher Ehnd Mekehnikal Kolledzh

APPLICATION OF MELANOCORTIN FOR TREATING INSULIN SENSITIVITY Russian patent published in 2012 - IPC A61K38/08 A61K38/12 A61K38/33 A61P5/50

Abstract RU 2453328 C2

FIELD: medicine.

SUBSTANCE: invention refers to medicine and concerns a method of treating insulin resistance. A peripherally effective amount of melanocortin receptor-4 agonist is introduced in a patient. The melanocortin receptor-4 agonist represents cyclic peptides containing the core sequence His-D-Phe-Arg-Trp-Cys.

EFFECT: invention provides effective treatment of insulin resistance by the peptide melanocortin receptor-4 agonist in the peripheral introduction.

34 cl, 11 dwg, 13 tbl

Similar patents RU2453328C2

Title	Year	Author	Number
LIGANDS OF MELANOCORTIN RECEPTORS	2006	Dong Chzhen Ksin Moro Zhak-P'Er	RU2401841C2
METHOD FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCORTIN 4 RECEPTOR PATH	2016	Ploeg, Leonardus, H.T. Van Der Henderson, Bart Kuhnen, Peter	RU2785889C1
MELANOCORTIN RECEPTOR LIGANDS	2006	Dong Chzhen Ksin Moro Zhak-P'Er	RU2439079C2
MELANOCORTIN RECEPTOR LIGANDS	2006	Dong Chzhen Ksin Moro Zhak-P'Er	RU2380372C2
GLP-1 ANALOGUES	1999	Dong Zheng Ksin Koj Dehvid Kh.	RU2208015C2
ALPHA- AND GAMMA-MSH ANALOGUES	2013	Bosen Tomas	RU2668791C2
T-CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN p53	2020	Deniger, Dryu S. Malekzadekh, Pariza Rozenberg, Stiven A.	RU2830061C2
HYDANTOIN MODIFIED MELANOCORTIN RECEPTOR LIGANDS	2008	Dong Chzhen Ksin Deolivejra Dehniel B. Komstok Dzhinn Mehri	RU2450017C2
PEPTIDIC INTERLEUKIN-23 RECEPTOR INHIBITORS FOR ORAL ADMINISTRATION AND USE THEREOF FOR TREATING INFLAMMATORY INTESTINAL DISEASES	2015	Bourne, Gregory Bhandari, Ashok Cheng, Xiaoli Frederick, Brian Troy Zhang, Jie Patel, Dinesh V. Liu, David	RU2736637C2
KV1_3 BLOCKERS	2020	Munch, Henrik Fischer Jensen, Rasmus Bugge Madsen, Jens Kvist	RU2825633C1

RU 2 453 328 C2

Authors

Khejlem Khehzer A.

Kaller Majkl Devitt

Batler Ehndrju A.

Dates

2012-06-20—Published

2008-11-05—Filed